Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CACT-IHF trial of Qishen Yiqi Dripping Pills in ischemic heart failure
ChiCTR-TRC-11001863Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of qishen yiqi dripping pills in Ischemic congestive heart failure (ICM-HF) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: 6-minute walk test distance. Started Sep 2014; status: completed.
02
Drugs
qishen yiqi dripping pills
03
Conditions
Ischemic congestive heart failure (ICM-HF)
Beyond the preview
Go deeper on ChiCTR-TRC-11001863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001863.